Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Operating Expenses data on file, last reported at $14.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 2.92% year-over-year to $14.4 million; the trailing twelve-month figure through Mar 2026 stood at $56.5 million (up 2.99% YoY), and the FY2025 full-year result was $56.1 million, up 4.3% from the prior year.
• Operating Expenses improved to $14.4 million in Q1 2026, from $13.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $14.7 million in Q4 2024 to a low of $12.7 million in Q2 2024.
• A 4-year average of $13.7 million and a median of $13.5 million in 2024 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 14.71% in 2025, while the deepest fall reached 10.64% in 2025.
• Tracing CAMP's Operating Expenses over 4 years: stood at $13.5 million in 2023, then rose by 8.98% to $14.7 million in 2024, then declined by 10.64% to $13.1 million in 2025, then gained by 9.46% to $14.4 million in 2026.
• Business Quant data shows CAMP's Operating Expenses at $14.4 million in Q1 2026, $13.1 million in Q4 2025, and $14.4 million in Q3 2025.